Abstract | BACKGROUND: METHODS: RESULTS: The median follow-up was 17 months (range, 5-46 months). Six of seven patients have died. The disease-free survival was 12 months and the overall median survival was 25 months. The 1-, 2-, and 3-year survivals were 57%, 38%, and 20% respectively. Tumor histology of poorly differentiated adenocarcinoma with signet ring, lymphovascular invasion and perineural invasion appeared to be associated with a poor outcome. CONCLUSION:
|
Authors | Terence C Chua, Ju-Li Koh, Tristan D Yan, Winston Liauw, David L Morris |
Journal | Journal of surgical oncology
(J Surg Oncol)
Vol. 100
Issue 2
Pg. 139-43
(Aug 01 2009)
ISSN: 1096-9098 [Electronic] United States |
PMID | 19544356
(Publication Type: Journal Article)
|
Topics |
- Adenocarcinoma
(mortality, therapy)
- Adult
- Combined Modality Therapy
- Female
- Humans
- Hyperthermia, Induced
- Ileal Neoplasms
(mortality, therapy)
- Jejunal Neoplasms
(mortality, therapy)
- Male
- Middle Aged
- Peritoneal Neoplasms
(mortality, therapy)
- Prospective Studies
|